As of Jan 13
| +0.05 / +2.56%|
The 8 analysts offering 12-month price forecasts for BioDelivery Sciences International Inc have a median target of 4.25, with a high estimate of 8.00 and a low estimate of 3.00. The median estimate represents a +112.50% increase from the last price of 2.00.
The current consensus among 8 polled investment analysts is to Buy stock in BioDelivery Sciences International Inc. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.